Summary
The influence of a standardized breakfast on the single dose (5 mg) kinetics and effects of glipizide was examined in 9 healthy volunteers and in 14 diabetics not previously exposed to a sulfonylurea. In the volunteers, glipizide caused an increase in plasma insulin and a reduction in blood glucose both during continued fasting and when the drug was taken with the breakfast. Food intake did not influence the peak concentration, the elimination half-life or the bioavailability of the drug. However, food intake significantly delayed the absorption of glipizide by about 0.5 h. In the patients, glipizide produced a significant increase in plasma insulin and a significant diminution of the rise in blood glucose in response to the meal. Starting at breakfast and for 45 min thereafter serum glipizide concentrations were significantly higher when the drug was taken 0.5 h before the meal, than when ingested concurrently with it. With the former treatment, the increase in plasma insulin occurred earlier and the blood glucose reduction was pronouncedly greater than with the latter treatment. As the absorption of glipizide may be delayed by concurrent breakfast, this may help to explain, why the administration of glipizide 0.5 h before breakfast led to a more appropriate relation between the serum concentration of the drug and the metabolic impact of the meal, thereby promoting more appropriate insulin release and better glucose disposition than after concurrent intake of the drug and breakfast.
Similar content being viewed by others
References
Melander A (1978) Influence of food on the bioavailability of drugs. Clin Pharmacokinet 3: 337–351
Melander A, Danielson K, Hanson A, Rudell B, Scherstén B, Thulin T, Wåhlin E (1977) Enhancement of hydralazine bioavailability by concomitant intake of food. Clin Pharmacol Ther 22: 104–107
Melander A, Danielson K, Scherstén B, Wåhlin E (1977) Enhancement of the bioavailability of propranolol and metoprolol by food. Clin Pharmacol Ther 22: 108–112
Melander A, Danielson K, Scherstén B, Thulin T, Wåhlin E (1977) Enhancement by food of canrenone bioavailability from spironolactone. Clin Pharmacol Ther 22: 100–103
Melander A, Brante G, Johansson Ö, Lindberg T, Wåhlin-Boll E (1979) Influence of food intake on the absorption of phenytoin. Eur J Clin Pharmacol 15: 269–274
Melander A, Wåhlin E (1978) Enhancement of dicoumarol bioavailability by concomitant food intake. Eur J Clin Pharmacol 14: 441–444
Levy RH, Pitlick WH, Troupin AS, Green JR, Neal JM (1975) Pharmacokinetics of carbamazepine in normal man. Clin Pharmacol Ther 17: 657–668
Beermann B, Groschinsky-Grind M (1978) Gastrointestinal absorption of hydrochlorothiazide enhanced by concomitant intake of food. Eur J Clin Pharmacol 13: 125–128
Bates TR, Sequeira JA, Tembo AV (1974) Effect of food on nitrofurantoin absorption. Clin Pharmacol Ther 16: 63–68
Malmborg AS (1978) Absorption of erythromycin stearate after oral administration. Curr Med Res Opin 5: (suppl. 2) 15–18
Melander A, Danielson K, Hanson A, Jansson L, Rerup C, Scherstén B, Thulin T, Wåhlin E (1976) Reduction of isoniazid bioavailability in normal men by concomitant intake of food. Acta Med Scand 200: 93–97
Acocella G (1978) Clinical pharmacokinetics of rifampicin. Clin Pharmacokinet 3: 108–127
Welling PG (1977) How food and fluid affect drug absorption. Postgrad Med 62: 73–82
Melander A, Stenberg P, Liedholm H, Scherstén B, Wåhlin-Boll E (1979) Food-induced reduction in bioavailability of atenolol. Eur J Clin Pharmacol 16: 327–330
Sartor G, Melander A, Scherstén B, Wåhlin-Boll E (1980) Influence of food and of age on the single-dose kinetics and effects of tolbutamide and chlorpropamide. Eur J Clin Pharmacol 17: 285–293
Sartor G, Melander A, Scherstén B, Wåhlin-Boll E (1980) Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide. Diabetologia 18: 17–22
Sartor G, Scherstén B, Melander A (1978) Effect of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients. Acta Med Scand 203: 211–214
Wåhlin-Boll E, Melander A (1979) High-pressure liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum. J Chromatogr 164: 541–546
Marks V (1959) An improved glucose-oxidase method for determining blood, C.S.F. and urine glucose levels. Clin Chim Acta 4: 395–400
Scherstén B (1965) Clinical evaluation of a rapid enzyme strip method (Dextrostix) for blood glucose estimation. Acta Med Scand 178: 583–590
Coburn HJ, Carrol JJ (1973) Improved manual and automated colorimetric determination of serum glucose, with use of hexokinase and glucose-6-phosphate dehydrogenase. Clin Chem 19: 127–130
Balant L, Fabre J, Zahnd GR (1975) Comparison of the pharmacokinetics of glipizide and glibenclamide in man. Eur J Clin Pharmacol 8: 63–69
De Santis A (1978) Internal report. Istituto Carlo Erba per Richerche Terapeutiche, Milano, Italy
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wåhlin-Boll, E., Melander, A., Sartor, G. et al. Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects. Eur J Clin Pharmacol 18, 279–283 (1980). https://doi.org/10.1007/BF00563012
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00563012